Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125084132 | 12508413 | 2 | F | 20160708 | 20160629 | 20160713 | EXP | PT-PFIZER INC-2016307542 | PFIZER | 64.00 | YR | M | Y | 0.00000 | 20160713 | MD | PT | PT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125084132 | 12508413 | 1 | PS | SUNITINIB MALATE. | SUNITINIB MALATE | 1 | 50 MG, DAILY | 21938 | 50 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125084132 | 12508413 | 1 | Metastatic renal cell carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125084132 | 12508413 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125084132 | 12508413 | Diarrhoea | |
| 125084132 | 12508413 | Dysgeusia | |
| 125084132 | 12508413 | Fatigue | |
| 125084132 | 12508413 | Hypertension | |
| 125084132 | 12508413 | Hyponatraemia | |
| 125084132 | 12508413 | Mucosal inflammation | |
| 125084132 | 12508413 | Skin discolouration | |
| 125084132 | 12508413 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125084132 | 12508413 | 1 | 200803 | 200808 | 0 |